Online Submissions

Already have a Username/Password for American Journal of Disaster Medicine?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines


Please click here to go directly to online submission portal



The American Journal of Disaster Medicine (AJDM) is designed to provide physicians and other medical professionals with the essential informational tools they need as they seek to combine emergency medical and trauma skills with crisis management and new forms of triage.

American Journal of Disaster Medicine publishes original research articles, clinical reports, brief communications, articles related to new ideas or innovations, letters to the editor, editorials, invited book reviews, and meeting announcements.

Contact Information

Susan M. Briggs, MD

Editorial Office:

American Journal of Disaster Medicine 
470 Boston Post Road
Weston, MA 02493
Phone (781) 899 - 2702
Fax (781) 899 - 4900

Office Hours:

Monday through Friday 8:30 am - 5 pm (EST)

Manuscript Submission

Manuscripts submitted for consideration must not have been previously published (except as an abstract) and must not be under consideration for publication elsewhere.

AJDM encourages the online submission of materials to be considered for publication. Online submission (with instructions) is available at

Those without access to online submission may submit manuscripts to the Editor. Manuscripts submitted by mail must include one hard copy and a copy on computer disk. Each mailed submission must include one full set of original figures as well as figures on diskette or CD if possible. Manuscripts submitted by mail will be uploaded to the online system in the AJDM editorial office.


Submission of a manuscript to AJDM is taken as evidence that no portion of the text or figures has been published or submitted for publication elsewhere unless information regarding previous publication is explicitly cited and copyright permission obtained (fax or mail to AJDM editorial office - see above) at the time of manuscript submission. Permission should be obtained for both print and online publication.

Peer Review

Two independent peer reviews are typically solicited. At the discretion of the Section Editor, a third review may also be solicited. The Editor is responsible for all final decisions regarding acceptance or rejection, recommendations for revision, and final editing.

Manuscript Publication

Publication of material in AJDM should not be interpreted as an endorsement of the material contained therein. The publisher will send galley proofs of accepted manuscripts (pdf file) to the corresponding author via e-mail. Corrections and revisions should be returned to the publisher via e-mail as instructed. Authors are responsible for the accuracy of references and statistical computations. The author(s) acknowledge that the publisher reserves the right to charge authors for excessive revisions made to their galley proofs. Authors are responsible for all excessive revision charges associated with their article. Publication may be withheld if authors fail to fulfill these financial obligations.


Single reprints may be purchased online at; click on the "Abstracts" link and select year of publication to view all abstracts and purchase your selection. Reprints in quantities of 100 or more may be ordered from AJDM, 470 Boston Post Road, Weston, MA 02493; telephone: (781) 899-2702; fax: (781) 899-4900.

Copyright Transfer

All authors must sign the AJDM copyright transfer form. This form will be sent to you when the article has been accepted . The signed form must be received by mail or fax at the AJDM editorial office before an accepted manuscript can be forwarded for publication.

Author Responsibility

The corresponding author is responsible for ensuring that all individuals named as co-authors have made a major contribution to the manuscript. Authorship credit should be based on significant contributions to all of the following: 1) conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting of the manuscript or critical revision of the manuscript for important intellectual content; and 3) final approval of submitted manuscript. Each author must declare his or her contribution to the manuscript on the copyright transfer form from the AJDM editorial office.

Financial Disclosure/Conflict of Interest

Authors are required to disclose, in a cover letter accompanying their manuscript, any relevant conflict of interest, including direct or indirect financial interests they may have in the materials or subject matter dealt with in the manuscript. This information will be held in confidence by the Editor during the review process but, at the discretion of the Editor, may be included in publication of an accepted manuscript.

Group Authorship

AJDM allows research groups to be recognized in submitted manuscripts. Two options are available.
1. The names of individuals appear in the byline designated as writing for the research group (e.g., Smith A, Johnson R, Williams T; for the CleftCran Research Group). The named individuals must meet the full criteria and requirements for authorship as described in the previous section. Other group members who do not qualify for authorship may be listed in an Acknowledgment.
2. Only the name of the research group appears in the byline, with an asterisk indicating that the list of authors qualifying for authorship appears at the end of the article (e.g., The CleftCran Research Group*). Again, other group members who do not qualify for authorship may be listed in the Acknowledgment.

Patient Anonymity

The author is responsible for ensuring the protection of a patient's anonymity. A signed consent form must accompany any figure including recognizable individuals. Shading of the eyes is not an acceptable means of rendering an individual unrecognizable. If an author chooses to use his/her own institutional patient permission form, it must include permission to use photographs for all types of publication including but not limited to print, visual, electronic, or broadcast media. Consent forms should be mailed or faxed to the AJDM editorial office.

Humans and Animals in Research

For manuscripts describing the results of experimental studies on humans, the authors must provide a statement in the Methods section of the manuscript that an institutional review board (IRB) approved the study and that informed consent was obtained. If a formal IRB is not available, the authors must include a statement in the manuscript that principles outlined in the Declaration of Helsinki were followed. Information regarding the Declaration of Helsinki may be found


Submission Categories

Original Articles: Reports of original clinical or basic science data pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention, including systematic reviews and meta-analysis that represent a new contribution to the field.
Clinical Reports: Case reports presenting new or novel clinical information.
Ideas and Innovations: Short communications related to novel ideas, techniques, methods of assessment, etc. 
Brief Communications: Preliminary or limited results (fewer than 1500 words, up to three figures or tables) of original research pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention. 
Letters to the Editor: Comments in the form of letters that express differences of opinion or supporting views of recently published AJDM content.
Editorials: Brief substantiated commentaries (fewer than 1000 words) on subjects of interest to the AJDM readership. Editorials should be narrative in form.


The American Medical Association Manual of Style is the standard reference for manuscript style. Manuscripts should be typed, double-spaced with 1" margins, and left justified. Use a standard 12-point font. Pages should be numbered consecutively in the upper right-hand corner. Do not print a running title. Turn off your word processing program's hyphenation feature and "smart quotes" feature before typing. Headings must be used to designate the major divisions of the manuscript. Up to three levels of headings may be used.

Title Page

Page one must include:

  • Title (maximum 20 words)
  • Author names with degrees, in the order that they will appear in print
  • Academic rank or position and institutional affiliation for each author
  • Name, address, telephone number, fax number, and e-mail address of the corresponding author who will receive editorial correspondence and reprint requests
  • If applicable, statement that paper was presented orally at a professional meeting, including the name, date, and location of the meeting
  • Credits and appropriate grant numbers if the study was supported by an agency
  • Running title (eight words or less)


Original articles and ideas and innovations articles should include a structured abstract of no longer than 250 words with the following headings and information, as applicable. Clinical reports should include an unstructured abstract of no longer than 100 words describing the objective, essential features and uniqueness of the case being presented, and conclusions. Structured abstracts of no longer than 150 words should be used for data-based Brief Communications articles. Non-data-based Brief Communications should include an unstructured abstract of no longer than 100 words.

Structured Abstract

Objective: State the main question or objective of the study and the major hypothesis tested, if any.
Design: Describe the design of the study indicating, as appropriate, use of randomization, blinding, criterion standards for diagnostic tests, temporal direction (retrospective or prospective), etc.
Setting: Indicate the study setting, including the level of clinical care (for example, primary or tertiary, private practice or institutional).
Patients, Participants: State selection procedures, entry criteria, and numbers of participants entering and finishing the study.
Interventions: Describe the essential features of any intervention, including the methods and duration of administration.
Main Outcome Measure(s): The primary study outcome measures should be indicated as planned before data collection began. If the hypothesis being reported was formulated during or after data collection, this fact should be clearly stated.
Results: Describe measurements that are not evident from the nature of the main results and indicate any blinding. If possible, the results should be accompanied by confidence intervals (most often the 95 percent interval) and the exact level of statistical significance. For comparative studies, confidence intervals should relate to the differences between groups. Absolute values should be indicated when risk changes or effect sizes are given.
Conclusions: State only those conclusions of the study that are directly supported by data, along with their clinical application (avoiding overgeneralization) and/or whether additional study is required before the information should be used in clinical settings. Equal emphasis must be given to positive and negative findings of equal scientific merit.
Key Words: A short list of the key words that reflects the article's content should follow the abstract.

(Reproduced with permission from: Haynes RB et al.: More informative abstracts revisited. Ann Intern Med. 1990; 113: 69-76).


If a statistical analysis is conducted, explanation of the methods used must precede the Results section in the manuscript. Unusual or complex analysis methods should be referenced.


Tables should be numbered consecutively using Arabic numerals. Each table should have an appropriate title and explanation at its head. Tables may be submitted as part of the manuscript document file, with each table placed on a separate page following the references. Alternatively, tables may be submitted electronically as separate files, with one table per file, in either .doc (text) or .xls (spreadsheet) format.


All figures and illustrations must be original photographs or artwork. Figures should be numbered consecutively in the order in which they appear in the manuscript, using Arabic numerals. A list of figure legends must be included on a separate page following the body of the manuscript. The legend should explain each figure in detail. A figure may include multiple images (a, b, c, etc.) but all must appear on the same page.

Figures should be submitted in one of the following formats: tif, eps, jpg, pdf. Each figure should be submitted as a separate file. Composite figures made up of more than one image should be submitted as separate files (e.g., Fig 1A, Fig 1B).

Color (CMYK) or grayscale images containing only pictures (no text or thin lines) should be scanned at a resolution of 300 dpi and an image width of at least 3.25". Color (CMYK) or grayscale images containing a combination of pictures and text or thin lines should be scanned at 600 dpi and an image width of at least 3.25". Monochrome (black and white) images such as line art or line graphs should be scanned at a resolution of 1200 dpi. For symbols that must be explained, please use a key that can be shot with the figures. Do not explain them using symbols in the figure legend. Authors may be charged if artwork has to be generated to incorporate figure symbols into the figure legend.

Figures submitted at lower than the required resolutions stated above will be allowed for review purposes. However, the publication process for accepted manuscripts will be delayed until acceptable images have been submitted.

Units of Measure/Abbreviations

The metric system is preferred for expressing units of measure. Abbreviations may be used for terms. Write out the full term for each abbreviation at its first use in the text, unless the abbreviation is a standard unit of measure. Abbreviations used in a table must be explained in a footnote below the table. For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources.


Acknowledge all forms of financial support on the title page. List all other acknowledgments in a paragraph at the end of the manuscript.


References are organized in AMA format; that is, they are to be cited numerically in the text and in consecutive order, including the first three authors followed by et al., and listed at the end of the article in the following format:

Journal articles— 1. Mudd P, Smith JG, Allen AZ, et al.: High ideals and hard cases: The evolution of opioid therapy for cancer pain. Hastings Cent Rep. 1982; 12(2): 11-14.

Books— 1. Bayles SP (ed.): Nutritional Supplements and Interactions with Analgesics. Boston: GK Hall & Co., 1978.

Book chapters— 1. Martin RJ, Post SG: Introducing alternative prescribing strategies. In Smith J, Howard RP, Donaldson P (eds.): The Oncology Management Handbook. Madison, WI: Clearwater Press, 1998, pp. 310-334.

Web sites— Health Care Financing Administration: HCFA Statistics at a glance. Available at: www.hcfa/gov/stats/stahili.htm. Accessed December 27, 2002.



Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in Microsoft Word, OpenOffice, PDF or RTF document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Copyright Notice

Copyright 2007-2023, Weston Medical Publishing, LLC 
All Rights Reserved


Privacy Statement

Privacy and User Data Policy

GDPR Update:

The data collected from registered and non-registered users of this journal falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process; it is used to informs readers about the authorship and editing of content; it enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.

This journal’s editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform may be shared with its developer Public Knowledge Project in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.

Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification; (b) right of access; (c) the right to be forgotten; (d) data portability; and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.

Requests per item (a) through (e) above should be sent to the journal's mailbox, ajdm(at)

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

What Data does this Website Process?


The system, based the PKP Open Journal System applications, process personal data as a fundamental part of their operations. Most data is only provided by consent, ie. through manual user registration, though some visitation data (eg. cookies, usage logs) may also be recorded.


User Registration Data


When a visitor creates a user account in a PKP application, the following personal information is processed and stored (with some minor variation between OMP and OJS, and from version to version):

●   Salutation

●   First name*

●   Middle name

●   Last name*

●   Suffix

●   Username

●   Gender

●   Password (encrypted)

●   Email address*

●   ORCiD ID

●   Website

●   Mailing Address

●   Country

●   Phone

●   Fax

●   Affiliation

●   Biography

●   Registration date

●   Last login date

●   Locales

●   Reviewing interests

●   Role registrations (author, reader, and/or reviewer)

Only the username, first name, last name, email and password fields are required.




This information is stored in the application database. Only the user password

is encrypted.


Availability and Access


This information is available to the user via their User Profile (and, with the exception of the username and dates, can be edited). System administrators, journal managers, and editors can also access and edit this data (except the username and dates) via the application back end. The data can be downloaded by journal managers in XML format. The data is not otherwise publicly available.




This data can be erased by the journal manager using the Merge Users tool, without affecting any editorial records. The erasure is subject to the considerations raised in the section “Scholarly Publishing, Data Privacy, and the Public Interest”, above.


Contributor Metadata Information


When a manuscript is submitted to a PKP application, contributor information is included. Contributors can be authors, translators, volume editors, and so on. This information is stored as submission metadata and is provided as part of any published manuscript record. The following contributor information is collected:


●   Salutation

●   First name*

●   Middle name

●   Last name*

●   Email address*

●   Suffix

●   ORCiD ID

●   Website

●   Country*

●   Affiliation

●   Biography


Only the first name, last name, email address and country fields are required.




This information is stored in the application database.



Data Transfer


We do not sell or transfer to third parties user information from this system.


General Visitor Information


PKP applications also collect general visitor usage data, including:

● Cookie information, to manage session history. Cookies are required to maintain a login session in PKP applications.

● Optionally, detailed usage log data, including: IP address; pages visited; date visited; and browser information, in application log files, as part of the Usage Statistics plugin. An anonymization option is available to privatize this information.

● Optionally, country, region and city information, in the metrics database. This data collection requires additional setup and is not enabled by default.


Other data may be tracked, either on the server or via third parties:

● Script loads from CDN servers;

● IP address information (including date, browser, etc.) in web server logs (separate from application log files as part of the Usage Statistics plugin).


Detailed instructions in limiting the amount of data you collect, and providing consent for the data you collect, can be found below.



Cookies: A cookie (usually titled “OJSSID” or “OMPSID”) is created when first visiting a PKP application and is stored on the visitor’s computer. It is only used to store a session ID, and to facilitate logins. (If the visitor blocks cookies, OJS will still work properly, though they will not be able to log in.)

Usage Statistics log files: As part of the usage statistics framework and plugin, OJS may store detailed application log files in the submission files directory (configured as the files_dir parameter in the OJS file), in a “usageStats” directory.

Geographical data: Filtered usage data, including possibly geographic data, is also stored in the OJS database, in a “metrics” table.


Availability and Access

Cookies: These are available via the visitor’s browser settings.

Usage Statistics log files: Only individuals with server file access can access application log files.

Geographical data: Journal Managers can access filtered usage data by using the OJS usage report plugins.



Cookies: These can be deleted via the visitor browser.

Usage Statistics log files: These can be erased by system administrators with file access.

Geographical data: This can only be erased by deleting records from the database directly, which also typically requires system administrator access.


Portions of this privacy statement are copyright by Simon Fraiser University Licensed wth CC4.0-BY.